Cipargamin
Product development
-
Patient exploratory
Novartis
Asexual blood stages
Transmission reduction
Uncomplicated malaria treatments and resistance management (TPP-1)
Severe malaria treatment (TPP-1)
Product vision |
|
MOA |
|
Key features |
|
Challenges |
|
Status |
|
Next milestone | |
Previously |
|
Project Director |
|